Return to Special Authority drug list
Generic name |
propranolol hydrochloride |
---|---|
Strength & form |
3.75 mg/mL oral solution |
Special Authority criteria |
Approval period |
---|---|
InitialFor the treatment of proliferating infantile1 hemangioma requiring systemic therapy when: Patient has life- or function-threatening hemangioma Patient has ulcerated hemangioma with pain or a lack of response to wound-care measures OR Patient’s hemangioma presents a risk of permanent scarring or disfigurement |
6 months |
RenewalFor the continued treatment of proliferating infantile hemangioma, when the patient has had an incomplete2 response to a 6-month course of treatment with propranolol oral solution |
6 months3 |